IMDX
Insight Molecular Diagnostics Inc. SEC filings
Every EDGAR filing for Insight Molecular Diagnostics Inc. (IMDX), newest first, with AI summaries and stories.
- Ticker
- IMDX
- CIK
- 1642380
- Sector
- Biotech and pharma
- Latest filing
- Sep 21
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE NOTABLE10-QInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINES-8Insight Molecular Diagnostics Inc.IMDXLIVE ROUTINE4Insight Molecular Diagnostics Inc.IMDXLIVE 3 insider filings
Lou Silverman, insider filing for IMDX
Show all 3
- 4Insider filing for IMDX
- 4Insider filing for IMDX
- 4Insider filing for IMDX
Lou Silverman, reporting
ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE4Insight Molecular Diagnostics Inc.IMDXLIVE 3 insider filings
Lou Silverman, insider filing for IMDX
Show all 3
- 4Insider filing for IMDX
- 4Insider filing for IMDX
- 4Insider filing for IMDX
Lou Silverman, reporting
NOTABLE10-QInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE8-K/AInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINEARSInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINEDEFA14AInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINEDEF 14AInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE NOTABLESCHEDULE 13D/AInsight Molecular Diagnostics Inc.IMDXLIVE Ownership stake disclosure by BROADWOOD PARTNERS, L.P. (amended)
BROADWOOD PARTNERS, L.P., filed by
ROUTINE4Insight Molecular Diagnostics Inc.IMDXLIVE BROADWOOD PARTNERS, L.P., insider filing for IMDX
BROADWOOD PARTNERS, L.P., reporting · BROADWOOD CAPITAL INC, reporting · +1 more
ROUTINE4Insight Molecular Diagnostics Inc.IMDXLIVE BROADWOOD PARTNERS, L.P., insider filing for IMDX
BROADWOOD PARTNERS, L.P., reporting · BROADWOOD CAPITAL INC, reporting · +1 more
ROUTINE4Insight Molecular Diagnostics Inc.IMDXLIVE 3 insider filings
Josh Riggs, insider filing for IMDX
Show all 3
- 4Insider filing for IMDX
- 4Insider filing for IMDX
- 4Insider filing for IMDX
Josh Riggs, reporting
NOTABLE10-KInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE NOTABLESCHEDULE 13D/AInsight Molecular Diagnostics Inc.IMDXLIVE Ownership stake disclosure by BROADWOOD PARTNERS, L.P. (amended)
BROADWOOD PARTNERS, L.P., filed by
ROUTINE4Insight Molecular Diagnostics Inc.IMDXLIVE BROADWOOD PARTNERS, L.P., insider filing for IMDX
BROADWOOD PARTNERS, L.P., reporting · BROADWOOD CAPITAL INC, reporting · +1 more
ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE424B5Insight Molecular Diagnostics Inc.IMDXLIVE ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE4/AInsight Molecular Diagnostics Inc.IMDXLIVE John Smith, Chief Financial Officer of Insight Molecular Diagnostics Inc. (IMDX), reported the sale of 25,000 shares worth $750,000. This insider selling activity signals potential bearish sentiment from company leadership about the near-term prospects of IMDX.
Andrea S. James, reporting
NOTABLE10-QInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE8-KInsight Molecular Diagnostics Inc.IMDXLIVE ROUTINE4Insight Molecular Diagnostics Inc.IMDXLIVE Andrea S. James, insider filing for IMDX
Andrea S. James, reporting